Hims & Hers introduced a new tracker to monitor shortages of GLP-1 weight loss and diabetes drugs, responding to the FDA's decision to end the compounded versions, Yahoo Finance reported Nov. 13.
HERSHEY, PA. — GLP-1 weight-loss drugs are having a “mild impact” on The Hershey Co.’s business, president and chief ...
Everyone is raving about the slimming power of semaglutide medications like Ozempic and Wegovy, which experts say is as ...
In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...
The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...
A new Northbrook pharma will work to bring its obesity treatment to market that it says holds advantages over Ozempic and its ...
They include MET-233i, an injectable amylin analog that is Metsera’s answer to the sector’s search for a once-monthly dosing ...
Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone density, a day after ...